Citigroup Raises Ionis Pharmaceuticals (NASDAQ:IONS) Price Target to $84.00
Citigroup upped their price target on Ionis Pharmaceuticals from $69.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday.
Source link
Similar Posts
Walmart, economic data await investors confronting AI ’whack-a-mole’
Walmart, economic data await investors confronting AI ’whack-a-mole’ Source link
How We Develop: As People, As Traders
11/21/2025 – The greatest part of our psychological growth occurs through social roles. When we take on a role with others, we inevitably receive feedback about who we are and how we perform and we internalize that feedback. When we take on many social roles, we absorb a wide range of such feedback and…
Meta to Invest in AI-Powered Humanoid Robots – Equitypandit
February 17, 2025February 17, 2025 Meta Platforms Inc. is focusing on AI-powered humanoid robots and investing in developing AI, sensors, and software for robots to be sold by other companies. The project, led by Marc Whitten (former CEO of General Motors’ Cruise division), is being developed within Meta’s Reality…
Why Now Is the Perfect Time for IPOs: Insights from Dr. Chiang
In a rapidly evolving economic landscape, timing plays a critical role in business decisions, especially when considering an Initial Public Offering (IPO). Dr. Clemen Chiang, CEO and Founder of Spiking, shares valuable insights in his recent article on Fast Company, delving into why the current moment offers unprecedented opportunities for companies to go public. Dr….
